$3.160
-0.134 (-4.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EDIT Prediction & Forecast by Similar Chart Analysis
Alphio's EDIT stock price prediction model matches the current Editas Medicine Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.13 (-0.99%). The 1-week path is $3.29 (+4.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Editas Medicine Inc Stock?
Editas Medicine Inc is a good buy right now due to its recent performance and promising developments. The current price is $3.16, with a significant year-to-date change of +54.15%, indicating strong momentum. The RSI is at 54.6, suggesting the stock is neither overbought nor oversold, which is favorable for entry. Analyst targets suggest potential upside, with one firm setting a target of $15, indicating a potential upside of nearly 373% from the current price. The main risk is the company's high net loss of $18.23 million in Q2 2026, which reflects ongoing financial challenges.
EDIT stock price ended at $3.16 on Friday, after losing -4.24%
Editas Medicine Inc (EDIT) last closed at $3.16, losing -4.24%. These facts feed the 1-day and 1-week EDIT price prediction above.
Analyst Consensus
Editas Medicine Inc (EDIT): 4 buy, 4 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Editas Medicine Inc (EDIT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches EDIT, ranked by similarity.
Seasonality analysis for EDIT
Historically the probability of a positive August return for EDIT is 65.08%. June offers the highest probability of a positive month at 68.33%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EDIT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.68 | $3.50 | $4.09 | +10.68% |
| Sep 2026 | $2.50 | $2.84 | $3.54 | -10.12% |
| Oct 2026 | $3.46 | $3.63 | $3.73 | +14.94% |
| Nov 2026 | $2.76 | $2.92 | $3.42 | -7.55% |
| Dec 2026 | $2.59 | $2.96 | $3.62 | -6.28% |
In 2026, Editas Medicine Inc (EDIT) is projected to range from $2.50 to $4.09.
Editas Medicine Inc 2026 monthly forecast
In Aug 2026, Editas Medicine Inc is projected to average $3.50, with a low of $2.68 and high of $4.09.
In Sep 2026, Editas Medicine Inc is projected to average $2.84, with a low of $2.50 and high of $3.54.
In Oct 2026, Editas Medicine Inc is projected to average $3.63, with a low of $3.46 and high of $3.73.
In Nov 2026, Editas Medicine Inc is projected to average $2.92, with a low of $2.76 and high of $3.42.
In Dec 2026, Editas Medicine Inc is projected to average $2.96, with a low of $2.59 and high of $3.62.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。